PDX panels from common tumors
Active Awarded Last action
- Contract number
- 75N91018F00073
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $67,882,919
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 100% obligated
- $67,882,919.00 Current and potential, with all options
- Completion date 90% complete
- Current and potential, with all options
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $26,707,853 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $41,175,066 |
About this award
This is a federal contract award from the Department of Health and Human Services National Institutes of Health National Cancer Institute to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract, valued at $67,882,919.00, is a cost-plus-fixed-fee delivery order for the PDX PANELS FROM COMMON TUMORS project. The work is to be performed at the Fort Detrick facility in Maryland and has a completion date of September 25, 2027.
The contract does not have a set-aside designation. Key subcontractors include Hamilton Company, Fisher Scientific Company L.L.C., Franklin Young International Inc., Health Research, Inc. - Roswell Park Division, The Regents of the University of Colorado, The University of Iowa, and Ascension Via Christi Hospital. These subcontractors are providing a range of scientific equipment, laboratory services, biospecimen acquisition, and research support to the prime contractor. The contract supports the National Cancer Institute's work in developing clinically annotated patient-derived cancer models for the research community.
Quick answers
Who was awarded contract 75N91018F00073?
75N91018F00073 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 28, 2018.
How much is contract 75N91018F00073 worth?
The government has obligated $67,882,919 on 75N91018F00073.
Is contract 75N91018F00073 an order under another contract?
Yes. 75N91018F00073 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract 75N91018F00073 competed?
The extent of competition for 75N91018F00073 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award